A $10 billion settlement to end litigation over Johnson & Johnson's baby powder, which was recalled after it was alleged to ...

Johnson & Johnson MedTech announced that it intends to resume the rollout of its Varipulse platform in the U.S. after a ...

Johnson & Johnson, founded in 1886, makes and sells medical devices, pharmaceuticals, and consumer health products. Headquartered in New Brunswick, N.J., the company operates over 250 subsidiary ...

Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

The MedTech segment includes an elaborate range of medical devices and products used in cardiovascular intervention, orthopedic, interventional solutions, surgery, and vision fields. Johnson ...

Will there be a severe downturn as a result? No one can say for sure, but investing in companies that can handle market ...

Johnson & Johnson (JNJ) closed the latest trading day at $157.89, indicating a +1.87% change from the previous session's end. This move outpaced the S&P 500's daily gain of 0.24%. At the same time, ...

In 2021, Johnson & Johnson unveiled a plan to spin off its consumer products division to focus on pharmaceuticals and medical technology. The company completed the Kenvue spinoff to shareholders ...

Johnson & Johnson provides healthcare products across three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care ...

Johnson & Johnson is a multinational giant in consumer health, medical technology and pharmaceuticals. Historically best-known for Band-Aids, Tylenol, and baby products, it’s a major player in ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds.In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against ...

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and ...